One of my most joyous technology memories concerns Project Origami. The effort from Microsoft, Intel and others launched ultra-mobile PCs, or UMPCs. The devices, akin to squeezing a full Windows machine into something about the size of a midrange iPad, often complete with a physical keyboard, utterly fascinated me back around 2006. At that time … Read more
One of my most joyous technology memories concerns Project Origami. The effort from Microsoft, Intel and others launched ultra-mobile PCs, or UMPCs. The devices, akin to squeezing a full Windows machine into something about the size of a midrange iPad, often complete with a physical keyboard, utterly fascinated me back around 2006. At that time … Read more
One of my most joyous technology memories concerns Project Origami. The effort from Microsoft, Intel and others launched ultra-mobile PCs, or UMPCs. The devices, akin to squeezing a full Windows machine into something about the size of a midrange iPad, often complete with a physical keyboard, utterly fascinated me back around 2006. At that time … Read more
One of my most joyous technology memories concerns Project Origami. The effort from Microsoft, Intel and others launched ultra-mobile PCs, or UMPCs. The devices, akin to squeezing a full Windows machine into something about the size of an midrange iPad often complete with a physical keyboard, utterly fascinated me back around 2006. At that time … Read more
One of my most joyous technology memories concerns Project Origami. The effort from Microsoft, Intel and others launched ultra-mobile PCs, or UMPCs. The devices, akin to squeezing a full Windows machine into something about the size of an midrange iPad often complete with a physical keyboard, utterly fascinated me back around 2006. At that time … Read more
One of my most joyous technology memories concerns Project Origami. The effort from Microsoft, Intel and others launched ultra-mobile PCs, or UMPCs. The devices, akin to squeezing a full Windows machine into something about the size of an midrange iPad often complete with a physical keyboard, utterly fascinated me back around 2006. At that time … Read more
Oma Fertility is on a mission to improve in vitro fertilization. The company says it accomplishes this by offering clients better technology, respectful care, and ethical pricing. Founded by Gurjeet Singh in 2020, the company raised $71.5 million over three rounds of funding. Chrissy Meyer and Root Ventures invested in the last two rounds. I’m … Read more
Oma Fertility is on a mission to improve in vitro fertilization. The company says it accomplishes this by offering clients better technology, respectful care, and ethical pricing. Founded by Gurjeet Singh in 2020, the company raised $71.5 million over three rounds of funding. Chrissy Meyer and Root Ventures invested in the last two rounds. I’m … Read more
Oma Fertility is on a mission to improve in vitro fertilization. The company says it accomplishes this by offering clients better technology, respectful care, and ethical pricing. Founded by Gurjeet Singh in 2020, the company raised $71.5 million over three rounds of funding. Chrissy Meyer and Root Ventures invested in the last two rounds. I’m … Read more
My grandfather lived through an incredible period of technological change. He saw the invention of the automobile, the airplane and the rocket. He lived through the dawn of the atomic age and the mainframe computer. He didn’t live long enough to see the PC or the impact it would have on my professional life, but … Read more
Since the start of 2023, more than 150,000 people have been laid off at tech companies, large and small. That’s a staggering number of people who have been put out of work. When you think about how Meta, Amazon and Salesforce have handled these layoffs, the situation becomes even more grim. Salesforce announced in January … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more
Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. When The Cure’s frontman Robert Smith said he was “sickened” by Ticketmaster fees, many of us felt vindicated. The platform then refunded some fees, … Read more